Competitive intelligence on
small-molecule drugs and
the 80,000 global patents
covering them

Start your free trial now

No commitment — No credit card required

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: atovaquone

« Back to Dashboard

Summary for Generic Name: atovaquone

Tradenames:5
Patents:4
Applicants:5
NDAs:6
Drug Master File Entries: see list14
Suppliers: see list3
Therapeutic Class:Antiparasitics

Pharmacology for Ingredient: atovaquone

Clinical Trials for: atovaquone

Single Oral Dose Study of Atovaquone/Proguanil Hydrochloride Combination Tablets and Atovaquone Suspension
Status: Completed Condition: Malaria

Weekly Dosing of Malarone ® for Prevention of Malaria
Status: Completed Condition: Malaria

Antiretroviral Drug Interaction Study in Volunteers With HIV
Status: Completed Condition: HIV; PCP; Toxoplasmosis

Phase II Randomized Open-Label Trial of Atovaquone Plus Pyrimethamine and Atovaquone Plus Sulfadiazine for the Treatment of Acute Toxoplasmic Encephalitis
Status: Completed Condition: Toxoplasmosis, Cerebral; HIV Infections

Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and Children
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMX
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

A Treatment IND for 566C80 Therapy of Pneumocystis Carinii Pneumonia
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / Sulfamethoxazole
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine
Status: Completed Condition: Pneumonia, Pneumocystis Carinii; HIV Infections

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline Llc
MEPRON
atovaquone
TABLET;ORAL020259Nov 25, 1992DISCNNo<disabled><disabled>
Glaxosmithkline
MALARONE PEDIATRIC
atovaquone; proguanil hydrochloride
TABLET;ORAL021078Jul 14, 2000RXNo6,166,046*PED<disabled>Y<disabled>
Glaxosmithkline
MALARONE
atovaquone; proguanil hydrochloride
TABLET;ORAL021078Jul 14, 2000RXYes6,291,488*PED<disabled>Y<disabled>
Glenmark Generics
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE
atovaquone; proguanil hydrochloride
TABLET;ORAL091211Jan 12, 2011RXNo<disabled><disabled>
Glaxosmithkline
MALARONE PEDIATRIC
atovaquone; proguanil hydrochloride
TABLET;ORAL021078Jul 14, 2000RXNo6,291,488*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access , or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013  

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc